טוען...
LKB1/AMPK Pathway and Drug Response in Cancer: A Therapeutic Perspective
Inactivating mutations of the tumor suppressor gene Liver Kinase B1 (LKB1) are frequently detected in non-small-cell lung cancer (NSCLC) and cervical carcinoma. Moreover, LKB1 expression is epigenetically regulated in several tumor types. LKB1 has an established function in the control of cell metab...
שמור ב:
| הוצא לאור ב: | Oxid Med Cell Longev |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Hindawi
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6874879/ https://ncbi.nlm.nih.gov/pubmed/31781355 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/8730816 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|